Entrectinib | C31H34F2N6O2 - PubChem
Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer - ScienceDirect
Entrectinib治疗携带NTRK1/2/3、ROS1和ALK基因变异的儿科实体肿瘤，效果确切
Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies | Signal Transduction and Targeted Therapy
Rozlytrek (entrectinib) for the Treatment of Solid Tumours, Japan
Mechanism of entrectinib in NB. Abbreviation: NB, neuroblastoma. | Download Scientific Diagram
NTRK gene fusions as novel targets of cancer therapy across multiple tumour types - ScienceDirect
Entrectinib - Wikipedia
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma - ScienceDirect
Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor | Journal of Medicinal Chemistry
TRK inhibitors block NFKB and induce NRF2 in TRK fusion-positive colon cancer
Mechanism of action and in vivo activity of entrectinib in ALK-driven... | Download Scientific Diagram
Evolving role of entrectinib in treatment of NTRK-positive tumors | Future Oncology
New Targets in Non–Small Cell Lung Cancer | Oncohema Key
ROS1-dependent cancers — biology, diagnostics and therapeutics | Nature Reviews Clinical Oncology
Mechanism of action and in vivo activity of entrectinib in ALK-driven... | Download Scientific Diagram
ROZLYTREK (entrectinib) Mechanism of Action | HCP
Frontiers | NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance | Oncology
Profile of entrectinib and its potential in the treatment of ROS1-posi | LCTT
Cancers | Free Full-Text | Non-Canonical Thinking for Targeting ALK-Fusion Onco-Proteins in Lung Cancer | HTML
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer | Nature Reviews Clinical Oncology
Mechanism of action of entrectinib. Confirmation that the SCYL3-NTRK1... | Download Scientific Diagram
Frontiers | Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and ...
JCM | Free Full-Text | The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies | HTML
Frontiers | NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma | Oncology
Frontiers | The Evolving Role of Radiotherapy for Pediatric Cancers With Advancements in Molecular Tumor Characterization and Targeted Therapies | Oncology
